Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
93
Frequently Asked Questions
What is Market Cap of Biofrontera Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Biofrontera Inc market cap is $8.89M.
What is the 52-week high for Biofrontera Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biofrontera Inc 52 week high is $2.22 as of September 13, 2025.
What is the 52-week low for Biofrontera Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biofrontera Inc 52 week low is $0.536 as of September 13, 2025.
What is Biofrontera Inc stock price today?
Biofrontera Inc stock price today is $0.8599.
What was Biofrontera Inc stock price yesterday?
Biofrontera Inc stock price yesterday was $0.833.
What is the PE ratio of Biofrontera Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Biofrontera Inc’s P/E ratio is -0.38.
What is the Price-to-Book ratio of Biofrontera Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Biofrontera Inc P/B ratio is -1.8092.
What is the 50-day moving average of Biofrontera Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Biofrontera Inc 50-day moving average is $0.9056.
